Anne MacPherson

Title: Anne MacPherson: Innovator in Nucleic Acid Markers

Introduction

Anne MacPherson is a prominent inventor based in Kingswood, Australia. She has made significant contributions to the field of molecular biology, particularly in the development of nucleic acid markers that can determine predisposition to neoplasms and adenomas. Her work is crucial for advancing diagnostic and therapeutic applications in oncology.

Latest Patents

Anne MacPherson holds a patent for "Nucleic acid markers for use in determining predisposition to neoplasm and/or adenoma." This invention relates to novel nucleic acid molecules whose expression levels are indicative of the onset and progression of gastrointestinal tract neoplasms, such as adenomas. The patent encompasses isolated proteins encoded by these nucleic acid molecules and their derivatives, homologues, and analogues. The applications of her invention are extensive, including diagnostic and therapeutic uses for colorectal neoplasms.

Career Highlights

Throughout her career, Anne has been associated with Clinical Genomics Pty. Ltd., where she has been instrumental in advancing research in genetic markers. Her innovative work has positioned her as a key figure in the field of molecular diagnostics.

Collaborations

Anne MacPherson has collaborated with notable colleagues, including Robert James and Julianne Henry. These partnerships have further enhanced her research and contributions to the scientific community.

Conclusion

Anne MacPherson's work in developing nucleic acid markers represents a significant advancement in the field of molecular diagnostics. Her contributions are vital for improving the diagnosis and treatment of colorectal neoplasms.